Oncotarget

Research Papers:

Cold atmospheric plasma as a potential tool for multiple myeloma treatment

Dehui Xu, Yujing Xu, Qingjie Cui, Dingxin Liu, Zhijie Liu, Xiaohua Wang, Yanjie Yang, Miaojuan Feng, Rong Liang, Hailan Chen, Kai Ye and Michael G. Kong _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:18002-18017. https://doi.org/10.18632/oncotarget.24649

Metrics: PDF 1968 views  |   HTML 2925 views  |   ?  


Abstract

Dehui Xu1,2,*, Yujing Xu1,*, Qingjie Cui2, Dingxin Liu1, Zhijie Liu1, Xiaohua Wang1, Yanjie Yang3, Miaojuan Feng4, Rong Liang4, Hailan Chen5, Kai Ye6,7 and Michael G. Kong1,5,8

1State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, Shaanxi, 710049, P.R. China

2The School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, Shaanxi, 710049, P.R. China

3Department of Cardiovascular Medicine, First Affiliated Hospital of the Medical School, Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, P.R. China

4Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, 710032, P.R. China

5Frank Reidy Center for Bioelectrics, Old Dominion University, Norfolk, VA, 23508, USA

6School of Electronic and Information Engineering, Xi’an Jiaotong University, Xi’an, Shaanxi, 710049, P.R. China

7First Affiliated Hospital of the Medical School, Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, P.R. China

8Department of Electrical and Computer Engineering, Old Dominion University, Norfolk, VA, 23529, USA

*These authors have contributed equally to this work

Correspondence to:

Michael G. Kong, email: [email protected]

Kai Ye, email: [email protected]

Keywords: multiple myeloma; cold atmospheric plasma; reactive oxygen species; CD95; selective inactivation

Received: November 09, 2017    Accepted: January 30, 2018    Published: April 06, 2018

ABSTRACT

Multiple myeloma (MM) is a fatal and incurable hematological malignancy thus new therapy need to be developed. Cold atmospheric plasma, a new technology that could generate various active species, could efficiently induce various tumor cells apoptosis. More details about the interaction of plasma and tumor cells need to be addressed before the application of gas plasma in clinical cancer treatment. In this study, we demonstrate that He+O2 plasma could efficiently induce myeloma cell apoptosis through the activation of CD95 and downstream caspase cascades. Extracellular and intracellular reactive oxygen species (ROS) accumulation is essential for CD95-mediated cell apoptosis in response to plasma treatment. Furthermore, p53 is shown to be a key transcription factor in activating CD95 and caspase cascades. More importantly, we demonstrate that CD95 expression is higher in tumor cells than in normal cells in both MM cell lines and MM clinical samples, which suggests that CD95 could be a favorable target for plasma treatment as it could selectively inactivate myeloma tumor cells. Our results illustrate the molecular details of plasma induced myeloma cell apoptosis and it shows that gas plasma could be a potential tool for myeloma therapy in the future.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24649